Westaim Completes Sale of Remaining Interest in Skyward Specialty

Rhea-AI Summary

The Westaim (TSXV: WED) has successfully sold its remaining 1,919,639 common shares in Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD). This transaction, executed through a wholly-owned subsidiary, generated net proceeds of approximately US$79.0 million, after deducting commissions. The sale marks Westaim's complete exit from its investment in Skyward Specialty, a significant move that could potentially impact the company's financial position and future investment strategy.

Positive

• Westaim generated approximately US$79.0 million in net proceeds from the sale
• Complete divestment from Skyward Specialty, potentially freeing up capital for new investments or strategic initiatives

Negative

• Loss of future potential gains from Skyward Specialty's stock performance
• Reduction in Westaim's investment portfolio diversity

Financial Analyst

The sale of Westaim's remaining stake in Skyward Specialty is a significant financial event. The transaction, netting approximately US$79.0 million, represents a substantial cash influx for Westaim. This move could potentially strengthen Westaim's balance sheet and provide capital for new investments or strategic initiatives.

For Westaim shareholders, this divestment might signal a shift in the company's investment strategy. It's important to monitor how management plans to utilize these funds, as it could impact future growth prospects and shareholder value. The market's reaction to this sale will be telling - it may view this positively if investors believe Westaim can generate higher returns elsewhere.

However, divesting completely from Skyward Specialty also means Westaim loses exposure to potential upside in the insurance sector. Investors should carefully evaluate the long-term implications of this strategic decision on Westaim's portfolio diversification and growth potential.

Market Research Analyst

This transaction reflects broader trends in the insurance and investment sectors. Westaim's complete exit from Skyward Specialty suggests a strategic repositioning, possibly in response to changing market dynamics or opportunities in other sectors.

The timing of this sale is noteworthy. With Skyward Specialty now publicly traded on NASDAQ, Westaim may have capitalized on favorable market conditions to maximize returns. This move could indicate Westaim's confidence in Skyward's current valuation or a belief that growth potential lies elsewhere.

For the wider market, this transaction might spark interest in Skyward Specialty's stock, as a significant block of shares has now changed hands. It's worth monitoring if this leads to increased trading volume or price movements in Skyward's stock. Additionally, this sale could trigger other institutional investors to reassess their positions in both Westaim and Skyward Specialty.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.

TORONTO--(BUSINESS WIRE)-- The Westaim Corporation (“Westaim” or the “Company”) (TSXV: WED) is pleased to announce that it has sold all of the remaining 1,919,639 common shares it held, through a wholly-owned subsidiary, in Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD). The net proceeds from such sale, less commissions, were approximately US$79.0 million.

About Westaim

Westaim is a Canadian investment company specializing in providing long-term capital to businesses operating primarily within the global financial services industry. The Company invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Westaim’s strategy is to pursue investment opportunities with a focus towards the financial services industry and grow shareholder value over the long term. Westaim’s investments include significant interests in Arena and the Arena FINCOs. Arena and Arena FINCOs are defined in the notes to Westaim’s audited consolidated financial statements for the year ended December 31, 2023 and the related MD&A. The common shares of Westaim are listed on the TSX Venture Exchange (the “TSXV”) under the trading symbol “WED”.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240910447452/en/

For more information, contact:

J. Cameron MacDonald, President and Chief Executive Officer or

Robert T. Kittel, Chief Operating Officer

The Westaim Corporation

info@westaim.com

(416) 969-3333

Source: The Westaim Corporation

FAQ

How many Skyward Specialty (SKWD) shares did Westaim sell in this transaction?

Westaim sold 1,919,639 common shares of Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) in this transaction.

What were the net proceeds from Westaim's sale of Skyward Specialty (SKWD) shares?

The net proceeds from the sale of Skyward Specialty (SKWD) shares, less commissions, were approximately US$79.0 million.

Does Westaim still hold any shares in Skyward Specialty (SKWD) after this sale?

No, this sale represents Westaim's complete divestment of its remaining interest in Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD).

What is Westaim's stock symbol on the TSX Venture Exchange?

Westaim 's stock symbol on the TSX Venture Exchange is WED.